• 1. Evolutionary de novo design of phenothiazine derivatives for dye-sensitized solar cells?
  Vishwesh Venkatraman,Marco Foscato,Vidar R. Jensen,Bj?rn K?re Alsberg J. Mater. Chem. A, 2015,3, 9851-9860
• 2. Empowering microfluidics by micro-3D printing and solution-based mineral coating?
  Hongxia Li,Aikifa Raza,Qiaoyu Ge,Jin-You Lu,TieJun Zhang Soft Matter, 2020,16, 6841-6849
• 3. Elusive 2-aminofuran Diels–Alder substrates for a straightforward synthesis of polysubstituted anilines?
  Ana G. Neo,Ana Bornadiego,Jesús Díaz,Stefano Marcaccini,Carlos F. Marcos Org. Biomol. Chem., 2013,11, 6546-6555
• 4. Enabling high-throughput single-animal gene-expression studies with molecular and micro-scale technologies
  Jason Wan Lab Chip, 2020,20, 4528-4538
• 5. Evolving better nanoparticles: Genetic algorithms for optimising cluster geometries
  Dalton Trans., 2003, 4193-4207

Recent Advances in the Study of 4-Chloro-2-(isoxazol-5-yl)-5-methylphenol (CAS: 213690-32-5)

4-Chloro-2-(isoxazol-5-yl)-5-methylphenol (CAS: 213690-32-5) is a compound of significant interest in the field of chemical biology and medicinal chemistry due to its potential applications in drug discovery and development. Recent studies have focused on elucidating its pharmacological properties, synthetic pathways, and potential therapeutic uses. This research brief aims to provide an overview of the latest findings related to this compound, highlighting its chemical characteristics, biological activities, and future research directions.

The compound's unique structure, featuring an isoxazole ring and a chlorophenol moiety, has drawn attention for its potential as a scaffold for designing novel bioactive molecules. Recent synthetic chemistry efforts have optimized the production of 4-Chloro-2-(isoxazol-5-yl)-5-methylphenol, achieving higher yields and purity, which are critical for further pharmacological evaluations. Advanced spectroscopic techniques, including NMR and mass spectrometry, have been employed to confirm the compound's structure and purity, ensuring reliable data for subsequent studies.

In terms of biological activity, preliminary in vitro studies have demonstrated that 4-Chloro-2-(isoxazol-5-yl)-5-methylphenol exhibits moderate antimicrobial properties against a range of Gram-positive bacteria. These findings suggest its potential as a lead compound for developing new antibacterial agents, particularly in the face of rising antibiotic resistance. Additionally, molecular docking studies have indicated that the compound may interact with specific bacterial enzyme targets, providing a basis for structure-activity relationship (SAR) studies to optimize its efficacy.

Further investigations into the compound's mechanism of action have revealed its ability to inhibit key enzymatic pathways in microbial cells. For instance, recent research has shown that 4-Chloro-2-(isoxazol-5-yl)-5-methylphenol can disrupt the synthesis of bacterial cell walls by targeting essential enzymes involved in peptidoglycan biosynthesis. This mode of action aligns with the compound's observed bactericidal effects and supports its potential as a therapeutic agent.

Beyond its antimicrobial properties, 4-Chloro-2-(isoxazol-5-yl)-5-methylphenol has also been explored for its potential anti-inflammatory and anticancer activities. Early-stage studies have reported that the compound can modulate inflammatory cytokines in cell-based assays, suggesting a possible role in treating inflammatory diseases. Similarly, in vitro cytotoxicity assays have indicated selective activity against certain cancer cell lines, warranting further investigation into its anticancer mechanisms.

Despite these promising findings, challenges remain in the development of 4-Chloro-2-(isoxazol-5-yl)-5-methylphenol as a therapeutic agent. Issues such as solubility, bioavailability, and potential toxicity need to be addressed through systematic pharmacokinetic and pharmacodynamic studies. Recent advancements in formulation technologies, including nanoparticle-based delivery systems, may offer solutions to these challenges, enhancing the compound's therapeutic potential.

In conclusion, 4-Chloro-2-(isoxazol-5-yl)-5-methylphenol (CAS: 213690-32-5) represents a versatile compound with multiple pharmacological applications. Ongoing research efforts are focused on optimizing its synthetic routes, elucidating its biological mechanisms, and exploring its therapeutic potential in various disease models. Future studies should prioritize translational research to bridge the gap between laboratory findings and clinical applications, ultimately contributing to the development of novel therapeutics.

• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)